Tue. May 26th, 2026
Spread the love

Mr Jalal Arabi, the Permanent Secretary, State House, says the State House Medical Centre (SHMC), which currently offers free medical services to patients will be re-positioned to offer qualitative and efficient services.

Arabi disclosed this in a statement by Mr Attah Esa, the Deputy Director, Information in the State House, Abuja on Wednesday.

The Permanent Secretary was reacting to a recent media report on the state of the Medical Centre.

It will be recalled that the Daily Trust newspaper on Tuesday reported that patients at the State House Medical Centre were groaning over lack of drugs and equipment at the facility.

The clinic is meant to serve Nigeria’s president, vice president and their families as well as employees of the presidency and other privileged individuals.

However, the Permanent Secretary said that the management would among other things seek the commercialisation of the centre to boost its revenue base.

According to Arabi, the centre when commercial will also augment the appropriation it receives from the government in the quest for a better qualitative service.

“The centre is the only health centre in Abuja where patients are not required to pay a dime before consultation.

‘‘In other government hospitals in Abuja, patients are required to pay for consultation, treatment, laboratory tests and others but that has not been the case with the State House Medical Centre.

‘‘The centre offers free services, nobody pays a kobo for hospital card, consultations or prescriptions and this has taken a toll on the subvention the centre receives from the government.

‘‘We have some of the best equipment in the country. For instance, to maintain the MRI and other scan machines, we spend close to N2 million monthly. Yet we do not charge a dime for those who require MRI scans in the clinic,’’ he said.

Arabi said that the proposed reforms would ensure that those eligible to use the Centre were NHIS complaint with their Health Maintenance Organisations (HMOs) or primary health provider domiciled in the clinic.

He said that already NHIS desk had been created at the clinic where patients would be required to authentic their profile.

“If their HMOs are registered in other hospitals they will be required to transfer to the centre.

‘‘This is another way through which we can boost revenue generation at the hospital and this has started yielding results because the stark reality is there is no free lunch anywhere,’’ he said.

The permanent secretary also dismissed allegations of misappropriation and withholding of funds meant for medical supplies in the centre.

‘‘I know people will insinuate and give all sorts of reasons because they don’t ask but it will be foolhardy and madness for anybody in his senses to defraud a medical centre of a kobo and toying with people’s lives.

‘‘No sane person will do that, so the truth of the matter is the hospital is being run on subvention and appropriation; if it comes we pile the drugs.

“But, the truth is the drugs are always overwhelmed by the number of people who use the centre because it is not controlled,’’ he said.(NAN)

By admin

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.